Dharmesh Patel
About Dharmesh Patel
Dharmesh Patel is the Director of Global Biospecimen Imaging Management at Bristol Myers Squibb in New Jersey, with over 16 years of experience in clinical biomarker operations and research.
Title and Current Role at Bristol Myers Squibb
Dharmesh Patel currently holds the position of Director, Global Biospecimen Imaging Management at Bristol Myers Squibb. He began this role in June 2020 and is based in New Jersey, United States. His responsibilities include overseeing biospecimen imaging protocols and ensuring the efficient management and analysis of biological samples.
Previous Roles at Bristol Myers Squibb
Dharmesh Patel has held various positions at Bristol Myers Squibb over the years. Before his current role as Director, he was the Associate Director of Biomarker Operations (2018-2020) and the TM Planning & Execution Lead (2016-2018). He also served as the Sample Operation Lead - Execution (2015-2016) and Sample Operation Lead (2014-2015). His initial position at the company was as a Research Scientist from 2010 to 2014.
Experience at Pfizer
Prior to joining Bristol Myers Squibb, Dharmesh Patel worked at Pfizer for a total of 11 years. He served as a Research Scientist II from 2007 to 2010 and as a Research Scientist from 1999 to 2007. During his tenure at Pfizer, he contributed to various research initiatives and enhanced his expertise in clinical biomarker operations and biomarker discovery.
Educational Background
Dharmesh Patel holds a Bachelor of Science in Biology with an emphasis in Chemistry from Delaware Valley University, where he studied from 1992 to 1996. He also earned a Master of Science in Cell Biology and Biotechnology from the University of Sciences in Philadelphia. His academic background laid a solid foundation for his future roles in biomarker operations and clinical data management.
Early Career Experience
Dharmesh Patel's early career includes positions as a Research Assistant at Ecogen Inc (1996-1998) and DuPont Co (1998-1999). These roles provided him with fundamental experience in research and sample management, which he later applied in his positions at Pfizer and Bristol Myers Squibb.